- Article metrics
- Last updated: Fri, 10 Oct 2025 3:36:46 Z
CAR T cells with dual targeting of CD19 and CD22 in adult patients with recurrent or refractory B cell malignancies: a phase 1 trial
Access & Citations
-
- 82k
- Article Accesses
-
- 480
- Citations
Citation counts are provided by Dimensions and depend on their data availability. Counts will update daily, once available.
Online attention
- 155 tweeters
- 1 Facebook pages
- 55 news outlets
- 1 Redditors
- 2 Wikipedia page
- 414 Mendeley
This article is in the 99th percentile (ranked 2,059th) of the 453,429 tracked articles of a similar age in all journals and the 81st percentile (ranked 19th) of the 100 tracked articles of a similar age in Nature Medicine
View more on Altmetric
Altmetric calculates a score based on the online attention an article receives. Each coloured thread in the circle represents a different type of online attention. The number in the centre is the Altmetric score. Social media and mainstream news media are the main sources that calculate the score. Reference managers such as Mendeley are also tracked but do not contribute to the score. Older articles often score higher because they have had more time to get noticed. To account for this, Altmetric has included the context data for other articles of a similar age.
Mentions in news and blogs
-
Engineered Yeast Robots Destroy Inflammatory Molecules in an IBD Mouse Model
The Scientist Magazine -
荣登《自然-医学》封面!这种难治癌症终于遇到了克星
sina.com.cn -
科学家利用CD19和CD22双靶点CAR-T细胞治疗复发性或难治性B细胞恶性肿瘤
sina.com.cn
This list highlights individual mainstream news articles and blogs that cite the article. Not all news and blogs link to articles in a way that Altmetric can pick up, so they are not representative of all media. Altmetric are responsible for the curation of this list and provide updates hourly.